Ambrx Biopharma Inc. (NYSE:AMAM) Receives $21.88 Average Price Target from Brokerages
Shares of Ambrx Biopharma Inc. (NYSE:AMAM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price […]